Your browser doesn't support javascript.
loading
Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway.
Pauzaite, Tekle; Tollitt, James; Sopaci, Betul; Caprani, Louise; Iwanowytsch, Olivia; Thacker, Urvi; Hardy, John G; Allinson, Sarah L; Copeland, Nikki A.
Afiliação
  • Pauzaite T; Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK.
  • Tollitt J; Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK.
  • Sopaci B; Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK.
  • Caprani L; Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK.
  • Iwanowytsch O; Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK.
  • Thacker U; Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK.
  • Hardy JG; Materials Science Institute, Lancaster University, Lancaster LA1 4YW, UK.
  • Allinson SL; Department of Chemistry, Faculty of Science and Technology, Lancaster University, Lancaster LA1 4YB, UK.
  • Copeland NA; Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK.
Biomedicines ; 10(8)2022 Aug 19.
Article em En | MEDLINE | ID: mdl-36009559

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article